(Q51227849)

English

External validation of the 2008 Framingham cardiovascular risk equation for CHD and stroke events in a European population of middle-aged men. The PRIME study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

External validation of the 2008 Framingham cardiovascular risk equation for CHD and stroke events in a European population of middle-aged men. The PRIME study. (English)

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

Jean Ferrières

5

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

Philippe Amouyel

object named as

Philippe Amouyel

10

0 references

Jean-Bernard Ruidavets

7

object named as

Jean-Bernard Ruidavets

1 reference

Europe PubMed Central

1 April 2018

Pierre Ducimetière

11

object named as

Pierre Ducimetiere

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

author name string

Bilal Majed

1

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

Muriel Tafflet

2

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

Frank Kee

3

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

Bernadette Haas

4

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

Michèle Montaye

6

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

Dominique Arveiler

8

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

John Yarnell

9

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

Jean-Philippe Empana

12

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

PRIME study group

13

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

language of work or name

0 references

publication date

17 April 2013

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

Preventive Medicine

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

57

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

1

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

49-54

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

The Framingham prediction rule is not valid in a European population of treated hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Framingham stroke risk function in a large population-based cohort of elderly people: the 3C study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Stroke risk estimation across nine European countries in the MORGAM project.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Original and REGICOR Framingham functions in a nondiabetic population of a Spanish health care center: a validation study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Recalibration of a Framingham risk equation for a rural population in India.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohorts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Incremental predictive value of adding past blood pressure measurements to the Framingham hypertension risk equation: the Whitehall II Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Validity of the Framingham point scores in the elderly: Results from the Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Prediction of cardiovascular events in subjects in the second Australian National Blood Pressure study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

The Framingham risk function underestimated absolute coronary heart disease risk in Czech men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Ten-year risk prediction in French men using the Framingham coronary score: results from the national SU.VI.MAX cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

How to evaluate the calibration of a disease risk prediction tool

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

How Do American Stroke Risk Functions Perform in a Western European Population?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Probability of stroke: a risk profile from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the 'old' versus the 'new' Framingham equation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2013.04.003

7 January 2021

Identifiers

10.1016/J.YPMED.2013.04.003

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/23603213

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51227849&oldid=1924180719"